Shale Oil

The Shale Oil Antitrust Litigation consolidates claims from purchasers of crude oil and related products alleging that producers coordinated output and pricing in a manner that suppressed competition in the shale market. The Judicial Panel centralized the docket before Judge Matthew L. Garcia in the District of New Mexico in August 2024; with 26 actions now pending, the litigation remains in its early consolidated-pleading and case-management phase, well before any damages framework or settlement structure exists.

Commodity price-fixing MDLs like this one typically split into direct-purchaser and indirect-purchaser tracks, and that split matters for funding. Direct purchasers — refiners and other buyers who transacted with the alleged coordinating producers — generally support a cleaner pass-through and damages analysis than indirect purchasers further down the distribution chain, whose claims depend on more attenuated economic modeling. Until expert discovery clarifies which track (or both) survives class certification, claim-level advances are difficult to underwrite with confidence; available capital now is best directed at firm-level litigation costs. Funders active in commodity antitrust matters typically watch the same signal here: whether the pleaded conspiracy theory rests on documented communications among producers or on more inferential circumstantial evidence, since that distinction shapes how quickly the case clears a motion to dismiss and moves toward discovery.

For a firm assembling a roster of purchaser-side clients in this docket, inventory finance becomes more tractable once the court resolves class certification and the surviving damages model is defined — commodity antitrust classes, once certified, tend to be more homogeneous than consumer-product classes, which can support portfolio-level underwriting sooner than in more fragmented dockets. There is no medical-lien dimension to this claim set; structuring here is purely a function of purchaser tier, litigation cost exposure, and expected timeline through certification and merits discovery.

Criterica Capital's commercial litigation finance product is built for firms and purchaser-side clients navigating an early-stage commodity antitrust MDL of this kind. A structure and litigation brief covering the docket's procedural posture is also available for teams evaluating capital commitments before certification narrows the picture.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.